Enter your login e-mail to the account
Search
Search parameters
Search results
- Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - PACIENT AFTER MYOCARDIAL INFARCTION WITH ANGINA PECTORIS
MUDr. Jaroslav Sumbal, MUDr. Branislav Líška
(1/2006, Topic ) - Chyby a úskalí terapie statiny
MUDr. Lubor Goláň
(1/2004, Main topic ) - The main points of the new guidelines for management of acute myocardial infarction with ST-segment elevation – STEMI
prof. MUDr. Vasiľ Hricák, CSc., FESC
(5/2013, Review articles ) - The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Svetový deň diabetu: vážne upozornenia
Magdaléna Žiaková
(11/2009, Information & comments ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - The Importance of Omega – 3 Fatty Acids in the Treatment of Dyslipidemia
prof. MUDr. Daniel Pella, PhD.
(12/2009, Topic of the year ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - Adherence and how to influence it
doc. MUDr. Michal Vrablík, Ph.D.
(2/2014, Review articles ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - Reach target LDL cholesterol more effective dose of atorvastatin 30 mg in the practice of general practitioners
MUDr. Martin Čaprnda, PhD., MUDr. Ján Hencel, MSc., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2015, Original articles & case reports ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Avascular necrosis of femoral head
MUDr. Boris Šteňo, PhD.
(3–4/2013, Interdisciplinary consilium ) - Promoting prevention and treatment of cardiovascular disease through nutrition supplements
doc. MUDr. Štefan Farský, CSc., FESC
(5/2012, Review articles ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - Pán doktor, príďte! Zápisky lekára po 100 rokoch
MUDr. Jozef Jakuš
(4/2005, Relax ) - MANAGEMENT OF PATIENTS AFTER CORONARY REVASCULARISATION PROCEDURES: GENERAL PRACTITIONER`S
prof. MUDr. Vasiľ Hricák, PhD., MFSC.
(4/2005, Topic ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - Contemporary antiplatelet treatment in clinical practice
doc. MUDr. Jiří Špác, CSc.
(S3/2010, Supplement ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - PREVENTION OF THE ISCHEMIC HEART DISEASE
MUDr. Milan Luknár, MUDr. Branislav Líška
(4/2005, Topic ) - Care for patients after myocardial revascularization therapy in general practitioner`s office
Prof. MUDr. Vasiľ Hricák, PhD., FESC
(6/2016, Review articles ) - Statins and acute coronary syndrome
prof. MUDr. Ján Murín, CSc.
(1/2010, Review articles ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - Drug-induced myopathy with cholesterol-lowering and triacylglycerol-lowering agents
doc. MUDr. Peter Špalek, CSc., MUDr. Denis Richter
(1/2010, Interdisciplinary consilium ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - New options in diagnostics and treatment of familial hypercholesterolemia
MUDr. Šárka Tesařová, Prof. MUDr. Michal Vrablík, Ph.D.
(3/2019, Review articles ) - CONGESTIVE HEART FAILURE TREATMENT
prof. MUDr. Viliam Bada, CSc.
(11/2007, Topic ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - Svetový deň srdca 2009 aj s účasťou všeobecných lekárov
redakcia Solen
(10/2009, Focus ) - Srdcové zlyhávanie 2016 (HFA/ESC) a 3. svetový kongres o akútnom srdcovom zlyhaní, Florencia, Taliansko, 21. – 24. mája 2016, 1. časť
doc. MUDr. Marian Sninčák, PhD., mim. prof.
(4/2016, Events ) - CHRONIC ISCHEMIC HEART DISEASE – STABLE ANGINA: CURRENT DIAGNOSTIC AND TREATMENT POSSIBILITIES
MUDr. Stanislav Juhás, CSc.
(11/2007, Topic ) - Prevencia cievnych mozgových príhod
MUDr. Ivan Gogolák, PhD.
(S4/2008, Supplement ) - News in ESC/EAS recommendations 2019 for dyslipidemia management
MUDr. Ľubomíra Fábryová, PhD.
(6/2019, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic )
- DEPRESSION, CORONARY ARTERY DISEASE, AND MYOCARDIAL INFARCTION
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(4/2006, Review articles )
- Cerebral amyloid angiopathy
MUDr. Veronika Vestenická, PhD., MUDr. Stanislav Šutovský, PhD., MUDr. Zuzana Čarnická, PhD., doc. MUDr. Branislav Kollár, PhD., MUDr. Pavel Šiarnik, MUDr. Lucia Krížová
(3/2015, Case reports ) - Toxic myopathies
doc. MUDr. Edvard Ehler, CSc. , Prof. MUDr. Josef Zámečník, Ph.D.
(6/2016, Review articles ) - Statins and their influence on peripheral nervous system
doc. MUDr. Edvard Ehler, CSc.
(3/2020, Review articles ) - Stroke in diabetic patients
doc. MUDr. Jaromír Chlumský, Ph.D., prof. MUDr. Jindra Perušičová, DrSc., prof. MUDr. Milan Kvapil, CSc.
(1/2010, From the boundary of neurology ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Statins and neuroprotective effects
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN, PharmDr. Aleš Dvořák, MBA
(1/2021, Review articles ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles )
- HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy )
- Claudicatio intermittens ako dôležitý príznak ischémie končatín
prof. MUDr. Viera Štvrtinová, CSc.
(1/2018, Main topic ) - Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - Abstrakty
(1/2009, Abstracts ) - High cardiovascular risk in patient with critical limb ischaemia – principles of conservative treatment
MUDr. Peter Gergely
(3/2011, Main topic ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes )